HomePEN • NYSE
Penumbra Inc
$223.18
After Hours:
$223.18
(0.00%)0.00
Closed: Mar 28, 4:02:08 PM GMT-4 · USD · NYSE · Disclaimer
StockUS listed security
Previous close
$226.38
Day range
$222.71 - $228.43
Year range
$180.93 - $348.67
Market cap
8.64B USD
Avg Volume
411.46K
P/E ratio
96.23
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
284.68M28.69%
Operating expense
151.96M13.75%
Net income
54.22M1,298.45%
Net profit margin
19.05988.57%
Earnings per share
0.76375.00%
EBITDA
39.77M315.37%
Effective tax rate
-42.09%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
289.19M53.80%
Total assets
1.56B13.53%
Total liabilities
377.36M1.43%
Total equity
1.18B
Shares outstanding
38.70M
Price to book
7.43
Return on assets
5.79%
Return on capital
6.38%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
54.22M1,298.45%
Cash from operations
36.26M2,612.12%
Cash from investing
24.28M181.25%
Cash from financing
5.92M3.24%
Net change in cash
66.73M344.45%
Free cash flow
32.94M532.03%
About
Penumbra, Inc. is a medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. Wikipedia
Founded
2004
Employees
4,200
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu